SKU(재고 관리 코드):PAC472Hu01
Polyclonal Antibody to Fibulin 1 (FBLN1)
Polyclonal Antibody to Fibulin 1 (FBLN1)
Western blotting: 0.5-2µg/mL
;Immunohistochemistry: 5-20µg/mL
;Immunocytochemistry: 5-20µg/mL
;Optimal working dilutions must be determined by end user.
Product No.
PAC472Hu01
Organism Species
Homo sapiens (Human).
Source
Polyclonal antibody preparation
Host
Rabbit
Potency
n/a
Ig Type
IgG
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Label
None
Immunogen
RPC472Hu01-Recombinant Fibulin 1 (FBLN1)
Buffer Formulation
0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Traits
Liquid
Concentration
0.22mg/ml
Organism Species More
Rattus norvegicus (Rat)
Applications
WB; IHC; ICC; IP.
If the antibody is used in flow cytometry, please check FCM antibodies
UOM
20µl 100µl 200µl 1ml 10ml
SPECIFITY
The antibody is a rabbit polyclonal antibody raised against FBLN1. It has been selected for its ability to recognize FBLN1 in immunohistochemical staining and western blotting.
USAGE
Western blotting: 0.5-2µg/mL
Immunohistochemistry: 5-20µg/mL
Immunocytochemistry: 5-20µg/mL
Optimal working dilutions must be determined by end user.
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Magazine |
Citations |
Clin Exp Metastasis. |
Augmented expression of urokinase plasminogen activator and extracellular matrix proteins associates with multiple myeloma progression Pubmed:24807734 |
Proteomics Clinical Applications |
Comparative mass spectrometric and immunoassay‐based proteome analysis in serum of Duchenne muscular dystrophy patients Pubmed:26680509 |
PROTEOMICS - Clinical Applications |
Comparative mass spectrometric and immunoassay-based proteome analysis in serum ofDuchenne muscular dystrophy patients. pubmed:26680509 |
ENVIRONMENTAL RESEARCH |
Exploration of identifying novel serum biomarkers for malignant mesothelioma using iTRAQ combined with 2D-LC-MS/MS Pubmed: 33197421 |
Catalog No. |
Related products for research use of Homo sapiens (Human) Organism species |
Applications (RESEARCH USE ONLY!) |
RPC472Hu02 |
Positive Control; Immunogen; SDS-PAGE; WB. |
|
RPC472Hu03 |
Positive Control; Immunogen; SDS-PAGE; WB. |
|
RPC472Hu01 |
Positive Control; Immunogen; SDS-PAGE; WB. |
|
PAC472Hu02 |
WB; IHC; ICC; IP. |
|
PAC472Hu01 |
WB; IHC; ICC; IP. |
|
LAC472Hu71 |
WB; IHC; ICC. |
|
MAC472Hu21 |
WB; IHC; ICC; IP. |
|
MAC472Hu22 |
WB; IHC; ICC; IP. |
|
LAC472Hu72 |
WB; IHC; ICC. |
|
SEC472Hu |
Enzyme-linked immunosorbent assay for Antigen Detection. |
|
SCC472Hu |
Chemiluminescent immunoassay for Antigen Detection. |
|
LMC472Hu |
Magnetic Luminex Assay for Antigen Detection. |
|
PSC472Hu01 |
ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
|
KSC472Hu01 |
Main materials for "Do It (ELISA Kit) Yourself". |